We have observed
2 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 17, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
IODINATED FATTY ACID ESTERS CONTAINING A MINIMUM OF 50 PERCENT OF MONOIODOSTEARIC ACID ESTERS OR DERIVATIVES IN THE FORM OF A SOFT CAPSULE OR A GEL CAPSULE, OF USE DURING A NUCLEAR ACCIDENT
SYSTEMS AND METHODS FOR LINKING IMPLANTS AND REDUCING DEFORMITIES